The New England Journal of Medicine, 10/19/23

/0 Comments/in /by
The New England Journal of Medicine, 10/19/23
Improved Outcomes with Enzalutamide in Biochemically Recurrent Prostate
Stephen J. Freedland, M.D., Murilo de Almeida Luz, M.D., Ugo De Giorgi, M.D., Ph.D., Martin Gleave, M.D., Geoffrey T. Gotto, M.D., M.P.H., Christopher M. Pieczonka, M.D., Gabriel P. Haas, M.D., Choung-Soo Kim, M.D., Miguel Ramirez-Backhaus, M.D., Antti Rannikko, M.D., Ph.D., Jamal Tarazi, M.D., M.P.A., Swetha Sridharan, M.B., B.S., Jennifer Sugg, M.S., Yiyun Tang, Ph.D., Ronald F. Tutrone, Jr., M.D., Balaji Venugopal, M.B., B.S., M.D., Arnauld Villers, M.D., Ph.D., Henry H. Woo, M.B., B.S., D.Med.Sc., Fabian Zohren, M.D., Ph.D., and Neal D. Shore, M.D.

Influencing Best Practices for Genomic and Germline Testing in Urology – Abhishek Srivastava

/0 Comments/in /by
Influencing Best Practices for Genomic and Germline Testing in Urology – Abhishek Srivastava
 

Dr. Shore named 2023 Slotkin Lecturer for Outstanding Lecture

/0 Comments/in /by

Congratulations to Dr. Neal D. Shore for being awarded the NSAUA 2023 Slotkin Lecturer for the outstanding lecture entitled “Current Therapy of Advanced GU Malignancies and Incorporating Clinical Trials Into Your Practice” October 20-22, 2023.

Efficacy of National Comprehensive Cancer Network Guidelines in Identifying Pathogenic Germline Variants Among Unselected Patients with Prostate Cancer: The PROCLAIM Trial

/0 Comments/in /by

Neal D. Shore, MD, FACS, co-author

Understanding the Underutilization of Germline Genetic Testing in Prostate Cancer

/0 Comments/in /by

Understanding the Underutilization of Germline Genetic Testing in Prostate Cancer
July 12, 2023

Neal Shore, MD, FACS; David Wise, MD, PhD; and Sarah Nielsen Young, MS, LCGC
To read entire article, please click this link
https://dailynews.ascopubs.org/do/understanding-underutilization-germline-genetic-testing-prostate-cancer

AUA Chicago April 28 – May 1, 2023- Here We Come

/0 Comments/in /by

Our very own Neal D. Shore, MD, FACS, CURC Director, CPI (Certified Principal Investigator by the Association of Clinical Research Professionals) and Jennifer Sutton, RN, Certified Clinical Research Coordinator, Director of Nursing and Administration, will be attending AUA (American Urological Association) in Chicago at the end of April. https://www.auanet.org/aua2023

Dr. Shore will also be co-moderating an Independent Practice Symposium being Saturday, April 29, 2023, from 7:30 – 11:30 am CT at the AUA Annual Meeting in Chicago. #amerurological

https://www.eventscribe.net/2023/AUA2023/agenda.asp?startdate=4/29/2023&enddate=4/29/2023&BCFO=&pfp=Research&mode=&fa=&fb=&fc=&fd=

Perioperative Pembrolizumab Therapy In Muscle-Invasive Bladder Cancer: Phase III KEYNOTE-866 And KEYNOTE-905/EV-303

/0 Comments/in /by

Matthew D Galsky, Christopher J Hoimes, Andrea Necchi, Neal Shore, J Alfred Witjes, Gary Steinberg, Jens Bedke, Hiroyuki Nishiyama, Xiao Fang, Ritesh Kataria, Eric Sbar, Xieyang Jia & Arlene Siefker-Radtke

Click here to read the Future Medicine article.

Cost-Effectiveness and Budget Impact of Emerging Minimally Invasive Surgical Treatments for Benign Prostatic Hyperplasia

/0 Comments/in /by

Bilal Chughtai, Sirikan Rojanasarot, Kurt Neeser, Dmitry Gultyaev, Stacey L. Amorosi, Neal D. Shore

Click here to read the article.

Efficacy of Enzalutamide Plus Androgen Deprivation Therapy In Metastatic Hormone-Sensitive Prostate Cancer By Pattern of Metastatic Spread: ARCHES Post Hoc Analyses

/0 Comments/in /by

Andrew J. Armstrong, Neal D. Shore, Russell Z. Szmulewitz, Daniel P. Petrylak, Jeffrey Holzbeierlein, Arnauld Villers, Arun Azad, Antonio Alcaraz, Boris Alekseev, Taro Iguchi, Francisco Gomez-Veiga, Brad Rosbrook, Ho-Jin Lee, Gabriel P. Haas, and Arnulf Stenzl

Click here to read the article.